A traditional Chinese medicine composition for treating blood-rimmed pupils and a preparation method and use thereof

By using a combination of traditional Chinese medicine to invigorate qi, nourish yin, and resolve blood stasis, this method solves the problems of slow absorption of blood accumulation and significant side effects in existing treatments. It achieves safe and effective absorption of blood accumulation and improvement of vision, and is suitable for treating blood perfusion of the pupil in patients with qi and yin deficiency and blood stasis in the collaterals.

CN122398947APending Publication Date: 2026-07-17TEACHING HOSPITAL OF CHENGDU UNIV OF T C M
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202610771391.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-06-01
Publication Date
2026-07-17

AI Technical Summary

Technical Problem

Current treatments cannot effectively promote the absorption of intraocular hemorrhage, leading to a sudden drop in vision and surgical risks. Existing medications have significant side effects, and traditional Chinese medicine treatments are difficult to use precisely, which can worsen the condition.

Method used

A combination of traditional Chinese medicines, including Codonopsis pilosula, Astragalus membranaceus, Dioscorea opposita, Polygonatum sibiricum, Sanguisorba officinalis charcoal, Schizonepeta tenuifolia charcoal, Nelumbo nucifera rhizome, Cirsium japonicum, and Prunus persica kernel, is used for treatment via oral administration. Combining the traditional Chinese medicine theories of invigorating qi and nourishing yin and resolving blood stasis and unblocking collaterals, tablets, capsules, granules, or pills are prepared to treat blood stasis in the pupils due to deficiency of both qi and yin and obstruction of collaterals.

Benefits of technology

It significantly reduces the risk of side effects from traditional blood-cooling and hemostatic formulas, promotes the absorption of accumulated blood, shortens the course of the disease, improves vision, has high safety, no obvious side effects, and is suitable for long-term use.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN122398947A_ABST
    Figure CN122398947A_ABST
Patent Text Reader

Abstract

本发明提供了一种治疗血灌瞳神的中药组合物及其制备方法和用途,属于中药领域。它是由下述重量配比的原料药制备而成:太子参24‑36份、黄芪24‑36份、黄精16‑24份、山药16‑24份、地榆炭8‑12份、荆芥炭8‑12份、藕节24‑36份、小蓟12‑18份、桃仁4‑6份。本发明还提供了该中药组合物的制备方法和用途。本发明中药组合物原料组方立足“气为血之帅”理论,确立“脾虚失统、气不摄血”为核心病机,以太子参、黄芪益气健脾为君药,变“治血为主”为“治气为先”,突破了传统以凉血止血为主流的组方思路,全方配伍精妙,强调止血不留瘀、化瘀不伤正,温清并用,药性平和,安全无副作用,可长期应用,药材质量可控,剂型开发潜力大,可产业化生产。
Need to check novelty before this filing date? Find Prior Art